OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
January 02, 2014
Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.
December 12, 2013
FDA details efforts to evaluate potential risks from use of nanomaterials in drug products and discuss analytical considerations, impact on stability, safety, and toxicology effects.
OGD is under pressure to improve review operations.
December 04, 2013
Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
December 02, 2013
New policies and products seek to maintain access to pain medicines while curbing rampant abuse.
FDA is moving fast to implement the drug compounding provisions of the new Drug Quality and Security Act (DQSA), issuing new guidance to spur registration by outsourcing facilities just days after President Obama signed the new bill into law.